Drug
Sibutramine clinical trials
Also written Meridia, ABT-991 and Reductil.
How studies write it
Studies that test it under each name
Studies by the year they started
23 studies that test it; most in 2004 (5)
| Year | Studies |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 5 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 1 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
- Obesity
- 10
Who runs them
Industry 11 · Other 12
Abbott (5) · Yale University (2) · Mayo Clinic (2) · Eli Lilly and Company (2) · Promomed, LLC (1) · GlaxoSmithKline (1) · Merck Sharp & Dohme LLC (1) · AstraZeneca (1)
Often tested with
Tested in the same studies.
Orlistat (4) · Metformin (1) · Pramlintide (1) · Phentermine (1) · Diethylpropion (1) · LY-377604 (1)
Studies
Open first, then newest update. How each study uses sibutramine is read from its arms, and is right about nine times in ten.
Testing it · 23
- Efficacy and Safety of Sibutramin-containing Drugs in Patient With Alimentary ObesityCompletedPhase 4Promomed, LLCNCT05821543Written as metformin+sibutramine
- Treatment of Binge Eating in Obese Patients in Primary CareCompletedPhase 4Yale UniversityNCT00537810Written as Sibutramine
- Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped CareCompletedNot applicableYale UniversityNCT00829283Written as Sibutramine/Orlistat
- Studying the Effects of Sibutramine on Eating BehaviorTerminatedPhase 4New York State Psychiatric InstituteNCT01170364Written as Sibutramine
- A Study to Characterise the Physiology of Weight Loss and Regain Under Dietary, Behavioural and Pharmacological Interventions in Healthy Obese SubjectsCompletedPhase 1GlaxoSmithKlineNCT01597609Written as sibutramine
- LOSS- Louisiana Obese Subjects StudyTerminatedPhase 4Pennington Biomedical Research CenterNCT00115063Written as sibutramine, orlistat, diethylpropion
- A Functional Magnetic Resonance Imaging (fMRI) Study in Overweight and Obese Men (0000-103)CompletedPhase 1Merck Sharp & Dohme LLCNCT00914212Written as Comparator: sibutramine
- A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese SubjectsCompletedPhase 2AstraZenecaNCT00402077Written as sibutramine
- Sibutramine to Reduce Weight Gain and Improve Smoking Cessation RatesCompletedNot applicableUniversity of TennesseeNCT00037752Written as Sibutramine
- Sibutramine Versus Continuous Positive Airway Pressure (CPAP)in Obstructive Sleep Apnea (OSA) PatientsCompletedPhase 4Laval UniversityNCT00729963Written as Sibutramine
- The Effect of Weight Loss on Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome (PCOS)Status unknownPhase 4Aristotle University Of ThessalonikiNCT01475019Written as Sibutramine
- A Weight Loss Study in Overweight Men and WomenTerminatedPhase 2Eli Lilly and CompanyNCT00993421Written as Sibutramine
- Weight Loss in Response to Sibutramine (MERIDIA) is Influenced by the Inherited GenesCompletedPhase 4Mayo ClinicNCT00433641Written as sibutramine
- Assess the Additional Weight Loss Effect of Orlistat Used in Combination With SibutramineCompletedNot applicableGachon University Gil Medical CenterNCT01184560Written as Sibutramine
- A Long Term Study of Sibutramine and the Role of Obesity Management in Relation to Cardiovascular Disease in Overweight and Obese PatientsCompletedPhase 3AbbottNCT00234832Written as Sibutramine hydrochloride
- A Comparative Study of KES524 in Patients With Obesity DiseaseCompletedPhase 3Eisai LimitedNCT00165685Written as Sibutramine Hydrochloride Monohydrate
- Pharmacodynamic Effects of Sibutramine on Gastric Function in ObesityCompletedPhase 2Mayo ClinicNCT00330525Written as sibutramine
- A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.CompletedPhase 4AbbottNCT00234988Written as sibutramine hydochloride monohydrate
- Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian PopulationCompletedPhase 3AbbottNCT00677391Written as Sibutramine
- A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating DisorderCompletedPhase 3AbbottNCT00402584Written as sibutramine
See all 23 studies that test sibutramine →
Given in every arm · 1 — sibutramine is usual care beside what is tested
As the comparator · 3 — what is tested is compared with sibutramine
- A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With OverweightWithdrawnPhase 3Eurofarma Laboratorios S.A.NCT05209984Written as SIB Group Sibus (Sibutramine) 15mg
- Sibutramine-metformin Combination Versus Sibutramine and Metformin Monotherapy in Obese PatientsStatus unknownPhase 3Laboratorios Silanes S.A. de C.V.NCT00941382Written as Sibutramine
- A Study of Nasal PYY3-36 and Placebo for Weight Loss in Obese SubjectsCompletedPhase 2Nastech Pharmaceutical Company, Inc.NCT00537420Written as Sibutramine
Codes
What other systems call sibutramine · ClinicalTrials.gg INT003410
- MeSH (NLM) C058254sibutramineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) WV5EC51866SIBUTRAMINEConfirmed FDA, NLM, Wikidata
- RxNorm 36514Confirmed FDA, Wikidata
- Wikidata Q424151(RS)-sibutramineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C75965SibutramineOne source FDA
- DrugBank DB01105One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C058254 | sibutramine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | WV5EC51866 | SIBUTRAMINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 36514 | — | Confirmed FDA, Wikidata |
| Wikidata | Q424151 | (RS)-sibutramine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C75965 | Sibutramine | One source FDA |
| DrugBank | DB01105 | — | One source Wikidata |
Also registered as sibutramine hydrochloride (UNII OGM0YHD1WF · RxNorm 221160).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.